Predicting Glycemic Control in Patients With Impaired Fasting Glucose With Fasting Respiratory Exchange Ratio
Andrea Foppiani1,2, Federica Sileo1,2, Francesca Menichetti1
1Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), University of Milan, Milan 20133, Italy.
Journal of the Endocrine Society
|April 4, 2025
Summary
Fasting respiratory exchange ratio (RER) can predict prediabetes outcomes. Lower RER, indicating fat oxidation, is linked to better glucose control and resolution of impaired fasting glucose after lifestyle changes.
Area of Science:
- Metabolic health
- Endocrinology
- Clinical diagnostics
Background:
- Impaired metabolic flexibility is a hallmark of prediabetes, yet difficult to assess clinically.
- Current methods for metabolic flexibility assessment are not practical for routine healthcare.
Purpose of the Study:
- To investigate the link between fasting respiratory exchange ratio (RER) and glucose metabolism in prediabetes.
- To determine if fasting RER can predict outcomes of impaired fasting glucose following lifestyle interventions.
Main Methods:
- Cross-sectional analysis of 10,176 individuals to correlate fasting RER with glucose metabolism markers.
- Longitudinal study of 86 patients with impaired fasting glucose, divided into fat oxidation (RER < 0.775) and glucose oxidation (RER > 0.925) groups.
- Evaluation of fasting RER's impact on impaired fasting glucose resolution after a 1-year lifestyle intervention.
Main Results:
- Higher fasting RER correlated with elevated fasting glucose, insulin, and HOMA-IR in the cross-sectional cohort.
- The fat oxidation group demonstrated a significant reduction in fasting glucose and higher odds of achieving normal glycemia post-intervention.
- These improvements occurred independently of weight loss differences between groups.
Conclusions:
- Fasting RER is a practical clinical indicator of glucose metabolism and prediabetes progression.
- A lower fasting RER, signifying enhanced fat oxidation capacity, predicts better glycemic control and resolution of impaired fasting glucose.
- This measure offers valuable insights for managing prediabetes and guiding lifestyle interventions.
Related Concept Videos
Hypoglycemia and Glucagon
143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Glucose Homeostasis: Regulation of Blood Glucose
1.3K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.3K
Dipeptidyl Peptidase 4 Inhibitors
140
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
140


